On (b)(6) 2014, our affiliate in (b)(6) reported a pt with an ulcer od.The ulcer was reported "at the right side of conjunctiva".The cornea was reported as "fine" by the pt.The report states the pt's "eyes were fine on insertion and after removal; however, after 2-3 hours after removal her eyes became red.Pt went to see an eye doctor and was diagnosed with ulcer".The pt was rx with tobra eye drops, vigamox eye drops 0.5% and refresh plus eye drops 0.5%.On (b)(6) 2014, our affiliate in (b)(6) received treatment records.On (b)(6) 2014, we received a translation of the treatment record and noted the statement "pt has been diagnosed and treated with antibiotic eye drops due to microbial keratitis of the right eye.Further monitoring by visit is required".The status was changed to indicate a reportable event.No additional info was provided.Suspect product was reported as discarded by the pt but lot info was provided.Remaining lenses were requested but not returned.A device history review was performed: the batch record did not show any abnormalities in monomer and solution testing.All parameters tested were within specification.Al sterilization requirements were successfully completed.No quality events associated with this lot.The lot history review indicated split lot # 2058370432 was manufactured under normal conditions.If additional info is received, will report within 30 days of receipt.Serious reportable event trends are reviewed quarterly in franchise management review meetings.
|